RESPIR-102: A Double-Blind, Active-Controlled, Multiple-Ascending Dose, Phase 1b Study ofAerosolized RSP-1502 Delivered Via the PARI LC Plus? Nebulizer in Subjects with Cystic Fibrosis andChronic Pseudomonas aeruginosa Lung Infection

Project: Research project

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.

Medicine & Life Sciences